🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,57 USD

Máx. histórico

178,74

2144 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,17%

Rango 52 semanas

14,68 – 24,68

Variación hoy

-7,48%

Cierre anterior

18,99

Rango de hoy

17,44 – 18,92

Volumen hoy

1.859.162

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 23 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
27/09/2005 13,20 13,38 13,02 13,20 -0,90% 2,73% 9.383
26/09/2005 13,26 13,50 13,20 13,32 -1,33% 2,26% 19.500
23/09/2005 13,56 13,62 13,20 13,50 -0,44% 3,10% 16.617
22/09/2005 13,38 13,56 13,08 13,56 -0,88% 3,59% 24.667
21/09/2005 13,68 14,10 13,14 13,68 +0,88% 7,02% 18.533
20/09/2005 13,32 13,62 13,20 13,56 +3,67% 3,15% 25.333
19/09/2005 13,50 13,50 12,84 13,08 -4,39% 4,89% 20.517
16/09/2005 13,38 13,68 12,96 13,68 +3,64% 5,38% 15.600
15/09/2005 13,08 13,38 13,02 13,20 +0,00% 2,75% 9.050
14/09/2005 13,02 13,26 13,02 13,20 -0,90% 1,84% 6.267
13/09/2005 13,50 13,56 13,02 13,32 -2,20% 4,00% 10.817
12/09/2005 13,86 14,10 13,32 13,62 -0,87% 5,63% 18.183
09/09/2005 13,68 14,04 13,56 13,74 +1,78% 3,51% 22.933
08/09/2005 13,74 13,74 13,50 13,50 +0,00% 1,75% 7.167
07/09/2005 12,90 13,68 12,78 13,50 +3,69% 6,98% 23.933
06/09/2005 13,62 13,62 12,72 13,02 -4,41% 6,61% 20.933
02/09/2005 13,02 13,74 13,02 13,62 +2,25% 5,53% 14.600
01/09/2005 13,20 13,80 12,96 13,32 +3,26% 6,36% 32.550
31/08/2005 12,72 13,14 12,30 12,90 +1,90% 6,60% 31.283
30/08/2005 12,72 13,02 12,30 12,66 -1,40% 5,66% 21.517
29/08/2005 13,02 13,20 12,72 12,84 -2,73% 3,69% 14.900
26/08/2005 13,02 13,32 12,78 13,20 +0,00% 4,15% 10.133
25/08/2005 13,14 13,20 12,72 13,20 +1,85% 3,65% 7.950
24/08/2005 12,84 13,08 12,72 12,96 -0,46% 2,80% 9.100
23/08/2005 13,08 13,26 12,60 13,02 -0,91% 5,05% 12.567
22/08/2005 12,96 13,32 12,96 13,14 +0,92% 2,78% 11.367
19/08/2005 13,32 13,32 12,90 13,02 -0,46% 3,15% 5.883
18/08/2005 13,38 13,38 12,90 13,08 -0,46% 3,59% 8.100
17/08/2005 12,96 13,44 12,96 13,14 +0,46% 3,70% 8.733
16/08/2005 13,26 13,44 12,96 13,08 -2,68% 3,62% 10.200